Quality of Life in Patients Undergoing Colorectal Resection for Deep Infiltrating Endometriosis
Launched by CATHOLIC UNIVERSITY OF THE SACRED HEART · Jan 28, 2019
Trial Information
Current as of May 30, 2025
Completed
Keywords
ClinConnect Summary
All patients fit for the study will be asked to complete a visual analogue scales (VAS) for dysmenorrhea, deep dyspaurenia, dysuria, dyschesia and chronic pelvic pain (CPP) Patients will fill in the Endometriosis QoL Questionnaire (EHP30), the gastrointestinal well-being questionnaires Bristol Stool Chart, GSCG (Gastrointestinal Symptom Rating Scale), STAY (1 and 2), the Psychological General Well-Being Index (PGWBI), Generalized Self-Efficacy, CD-RISC - Connor-Davidson scale about their pre operative and actual status.
Surgery includes laparoscopic resection of all visible endometriosis, ...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Women aged between 18 and 45 years
- • Clinical diagnosis of deep endometriosis infiltrating the bowel
- • Women undergoing surgical removal with colorectal resection with or without loop ileostomy creation
- Exclusion Criteria:
- • History of previous or ongoing neoplastic pathology
- • Contraindications to surgical intervention
- • Not complete eradicating surgery
- • Psychiatric disorders
- • Surgical, spontaneous or pharmacological menopause - Intestinal surgery different from segmental bowel resection and colorectal anastomosis
About Catholic University Of The Sacred Heart
The Catholic University of the Sacred Heart is a prestigious academic institution in Italy, renowned for its commitment to advancing medical research and education. With a strong emphasis on ethical standards and community well-being, the university actively engages in clinical trials that contribute to innovative healthcare solutions. Its multidisciplinary approach leverages expertise from various fields, fostering collaborations that enhance the quality and impact of research. The university is dedicated to improving patient outcomes through rigorous science and compassionate care, aligning with its mission to serve the greater good.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Rome, , Italy
Patients applied
Trial Officials
Francesco Cosentino, MD
Principal Investigator
francesco.cosentino@fgps.it
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials